Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2014; 20(10): 2533-2541
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2533
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2533
Table 1 Summary of the results of the main studies which evaluated the performance of renal function markers and/or glomerular filtration rate estimates estimates comparatively to a reference method in patients with cirrhosis
Ref. | Number of patients | Reference method | Performance of the estimate(s) |
Papadakis et al[25], 1987 | 23 (mGFR = 66) | Inulin | Difference between mean mGFR and ClCr and CG -24 and -52 mL/min respectively in group with decreased mGFR (+10 and +4 in patients with normal mGFR) |
Caregaro et al[35], 1994 | 56 (mGFR = 86.7) | Inulin | Difference between mean mGFR and ClCr and CG -14.6 and -4.9 respectively. Mean overestimation was 51% and 40% respectively in patients with GFR < 80 |
Roy et al[36], 1998 | 30 (mGFR = 30) | Inulin | Mean relative overestimation 80% with ClCr when moderate to severe CKD |
Orlando et al[37], 1999 | 20 | Inulin | Mean relative overestimation of 4% and 23% respectively for ClCr and CG in Child C patients. Relative difference only +3% and -6% respectively in Child A patients |
Woitas et al[26], 2000 | 44 (mGFR = 37) | Inulin | Sensitivity to detect GFR < 90, 85.7% and 28.5% respectively for elevated CysC and SCr |
Demirtaş et al[27], 2001 | 26 (HRS) (mGFR = 33.5) | 99Tc-DTPA | Difference between mean mGFR and ClCr +7 |
Orlando et al[28], 2002 | 36 (mGFR = 71.5) | Inulin | Mean overestimation was 75% and 30% respectively for CG and ClCr in patients with decreased GFR (14% and 9% in patients with normal GFR). Sensitivity to detect GFR < 72 were 73%, 23%, 53% and 86% respectively for elevated CysC and SCr, CG and ClCr |
Gonwa et al[5], 2004 | 1447 (Pretransplant) (mGFR = 90.7) | 125I-Iothalamate | P30 were 60.8% and 66.7% for respectively CG and MDRD4. Difference between means mGFR and CG and MDRD4 +23.5 and +21.9 respectively |
Pöge et al[41], 2006 | 44 (mGFR = 35.3) | Inulin | Mean absolute bias and P30 was 51.7/4.5%, 48.3/6.8%, 33.3/11.4% and 33.9/13.6% for respectively CG, MDRD4, Hoek and Larsson GFR formula |
MacAulay et al[42] 2006 | 57 (mGFR = 83) | 99Tc-DTPAIohexol | Mean difference between formula and mGFR was lower for MDRD6 comparing with CG (+3.5 vs +15.4). However, mean absolute difference was high and similar (23.4 vs 23.6) and poor precision was found with both eGFR (root mean square error 31.5 vs 30.5 for respectively MDRD6 and CG) |
Francoz et al[31], 2010 | 157 (mGFR = 85) | Inulin | Mean absolute bias ± SD was 17 ± 32, 16 ± 29 and 8 ± 22 for CG, MDRD4 and CKD-EPI respectively. In patients with GFR < 70, CKD-EPI bias rose to 19 ± 20 |
Rognant et al[6], 2010 | 148 (Alcoholic Cirrhosis) (mGFR = 77) | Median absolute bias ± SD and P30 was 23 ± 23/33.3% and 22 ± 20/40% for CG and MDRD4 respectively | |
Kim et al[43], 2011 | 89 (normal SCr) (mGFR = 73) | 99Tc-DTPA | Difference between mean mGFR and ClCr, CG and MDRD6 was -14.4/+ 19.1 and -40.1 respectively. AUC of ROC to detect GFR < 60 was 0.721, 0.561, 0.463 and 0.659 for 1/CysC, ClCr, CG and MDRD6 respectively |
Xirouchakis et al[47], 2011 | 74 (mGFR = 81.7) | 51Cr-EDTA | Concordance correlation coefficient was 0.61, 0.38 and 0.46 for respectively MDRD4, Larsson and Hoek estimates. P30 was 64% for MDRD4 and 68% for Hoek. |
Gerhardt et al[48], 2011 | 44 (mGFR = 35.3) | Inulin | Median absolute bias and P30 was 40.1/6.8% and 42.5/6.8% for respectively MDRD175 and CKD-EPI |
De Souza et al[49], 2013 | 202 (Pretransplant) (mGFR = 83) | Inulin | Concordance correlation coeffcient and P30 was 0.75/78.7, 0.56/42.6, 0.62/56.4, 0.8/83.2 and 0.82/78.2 for respectively Hoek, MDRD175, CKD-EPI, CKD-EPI CysC and mixed CKD-EPI formula |
Table 2 Description of the characteristics of the studies used to develop the common glomerular filtration rate estimates
Name of the study | Number of patients | Country | Reference method | Marker(s) | Mean GFR | Comments |
CG 1976 | 249 | Canada | 24 h ClCr | SCr | 30-130 | No normalization on BSA |
Male patients only in the population of the study | ||||||
MDRD 1999 | 1628 | United States | Renal clearance 125I-Iothalamate | SCr | 39.8 ± 21.2 | Characteristics of the study population: |
Male 60% | ||||||
Black patients 12% | ||||||
> 55 yr 42% | ||||||
Diabetic patients 6% | ||||||
Re-expressed in 2007 to be used with IDMS traceable creatinine assay (MDRD 175) | ||||||
CKD EPI (PCr) 2009 | 8254 | United States | Various (urinary clearance of exogenous markers) | SCr | 68 ± 40 | Characteristics of the study population: |
Male 57% | ||||||
Black patiens 32% | ||||||
> 65 yr 13% | ||||||
Diabetic patients 29% | ||||||
Hoek 2003 | 123 | The Nederlands | Renal clearance 125I-Iothalamate | CysC | Median = 81 | Characteristics of the study population: |
Male 48% | ||||||
Median age 50 yr | ||||||
Diabetic patients 24% | ||||||
CKDEPI (Cys C and mixed PCr + CysC) 2012 | 5352 | United States | Various (urinary or plasma clearance of exogenous markers) | CysC alone and both CysC and SCr | 68 ± 39 | Characteristics of the study population: |
Male 58% | ||||||
Black patients 40% | ||||||
Age > 65 yr 13% | ||||||
Diabetic patients 32% | ||||||
Patients with BMI > 30 31% |
- Citation: Rognant N, Lemoine S. Evaluation of renal function in patients with cirrhosis: Where are we now? World J Gastroenterol 2014; 20(10): 2533-2541
- URL: https://www.wjgnet.com/1007-9327/full/v20/i10/2533.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i10.2533